Mandate

Vinge has advised Lendify in connection with a bond issue

February 07, 2018 Banking and Finance

Lendify AB (”Lendify”), a P2P-lending plattform, has issued bonds in the amount of SEK 400,000,000 on 29 January 2018 through its wholly-owned subsidiary Lendify Sweden 2 AB (publ).

The bonds have a tenor of two years and an annual interest rate of three-months Stibor + 4.5%. The bonds are backed by a portfolio of promissory notes issued by consumers in Sweden in favour of Lendify.

Together with the management of the company, Carnegie Investment Bank and DNB Markets as arrangers and their legal advisor, Vinge acted for Lendify in the structuring and documentation of the transaction.

Vinge’s team consisted of Albert Wållgren, Lionardo Ojeda and Sebastian Frisk.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025